Direct comparison of [11C] choline and [18F] FET PET to detect glioma infiltration: a diagnostic accuracy study in eight patients

[1]  A. Luciani,et al.  Reply to: "Response to: Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma". , 2018, Journal of Hepatology.

[2]  R. Boellaard,et al.  Quantification of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in glioma , 2018, EJNMMI Research.

[3]  J. Grellard,et al.  F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  R. Boellaard,et al.  Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis , 2017, American Journal of Neuroradiology.

[5]  Luke Vale,et al.  Intraoperative imaging technology to maximise extent of resection for glioma. , 2017, The Cochrane database of systematic reviews.

[6]  K. Brindle,et al.  Brain Tumor Imaging. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R. Boellaard,et al.  Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol. , 2016, Neurosurgery.

[8]  Ian Law,et al.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. , 2016, Neuro-oncology.

[9]  Christian Vanhove,et al.  Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats , 2016, PloS one.

[10]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[11]  J. C. Baayen,et al.  In Vivo Accuracy of a Frameless Stereotactic Drilling Technique for Diagnostic Biopsies and Stereoelectroencephalography Depth Electrodes. , 2016, World neurosurgery.

[12]  Jérémie F. Cohen,et al.  STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. , 2015, Clinical chemistry.

[13]  David Moher,et al.  STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies , 2015, BMJ : British Medical Journal.

[14]  Marion Smits,et al.  Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. , 2015, Neuro-oncology.

[15]  R. Boellaard,et al.  Reply: Simplified Methods for Quantification of 18F-Fluoromethylcholine Uptake: Is SUVAUC,PP Actually an SUV? , 2015, The Journal of Nuclear Medicine.

[16]  Lutz Tellmann,et al.  Dual-time-point O-(2-[18F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas , 2015, European Radiology.

[17]  Uwe Haberkorn,et al.  Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors. , 2014, Neuro-oncology.

[18]  J. Shinoda,et al.  Comparison of 11C-Methionine, 11C-Choline, and 18F-Fluorodeoxyglucose-Positron Emission Tomography for Distinguishing Glioma Recurrence from Radiation Necrosis , 2013, Neurologia medico-chirurgica.

[19]  Val J Lowe,et al.  Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. , 2013, Neuro-oncology.

[20]  K. Deblaere,et al.  Distribution Patterns of 18F-Labelled Fluoromethylcholine in Normal Structures and Tumors of the Head: A PET/MRI Evaluation , 2012, Clinical nuclear medicine.

[21]  U. Roelcke,et al.  F-18 Choline PET Does Not Detect Increased Metabolism in F-18 Fluoroethyltyrosine-Negative Low-Grade Gliomas , 2012, Clinical Nuclear Medicine.

[22]  Z. Bhujwalla,et al.  Choline metabolism in malignant transformation , 2011, Nature Reviews Cancer.

[23]  A. Kawashima,et al.  The utility of 11C-choline PET/CT for imaging prostate cancer: a pictorial guide. , 2011, AJR. American journal of roentgenology.

[24]  Michael Sabel,et al.  Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  J. Markert,et al.  Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide , 2011, Journal of medical imaging and radiation oncology.

[26]  M. J. van den Bent.  Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective , 2010, Acta neuropathologica.

[27]  Martin J. Bent,et al.  Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective , 2010, Acta Neuropathologica.

[28]  C. Daumas-Duport,et al.  Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities , 2010, Neurology.

[29]  W. Curran,et al.  Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. , 2009, International journal of radiation oncology, biology, physics.

[30]  Y. Muragaki,et al.  Metabolic Assessment of Gliomas Using 11C-Methionine, [18F] Fluorodeoxyglucose, and 11C-Choline Positron-Emission Tomography , 2008, American Journal of Neuroradiology.

[31]  Jochen Herms,et al.  FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[32]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[33]  K. Van Laere,et al.  EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  B. Weber,et al.  Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L-tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[35]  Karl-Josef Langen,et al.  O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. , 2005, Brain : a journal of neurology.

[36]  B. Weber,et al.  Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  Isabelle Salmon,et al.  Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  M. Coel,et al.  Combined Use of F‐18 Fluorocholine Positron Emission Tomography and Magnetic Resonance Spectroscopy for Brain Tumor Evaluation , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[39]  T. Hara,et al.  Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. , 2003, Journal of neurosurgery.

[40]  Karl Herholz,et al.  Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  H. Herzog,et al.  Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-l-tyrosine , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[42]  J. Edmeads,et al.  The Clinician's Perspective , 2001, Headache.

[43]  H. Minn,et al.  Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography , 2000, European Journal of Nuclear Medicine.

[44]  S. Goldman,et al.  Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  N A Obuchowski,et al.  Nonparametric analysis of clustered ROC curve data. , 1997, Biometrics.

[46]  B A Kall,et al.  Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. , 1987, Mayo Clinic proceedings.

[47]  C. Vanhove,et al.  (18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study. , 2015, Nuclear medicine and biology.

[48]  U. Haberkorn,et al.  Intra-individual comparison of 18 F-FET and 18 F-DOPA in PET imaging of recurrent brain tumors , 2014 .

[49]  H. Akaike,et al.  Information Theory and an Extension of the Maximum Likelihood Principle , 1973 .